Switch theme
Sign up to access all valuation multiples
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.
1987
8.7K+
LTM Revenue $1.3B
LTM EBITDA $262M
$2.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CompuGroup Medical has a last 12-month revenue (LTM) of $1.3B and a last 12-month EBITDA of $262M.
In the most recent fiscal year, CompuGroup Medical achieved revenue of $1.3B and an EBITDA of $232M.
CompuGroup Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See CompuGroup Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| Gross Profit | $1.3B | XXX | $1.1B | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 84% | XXX | XXX | XXX |
| EBITDA | $262M | XXX | $232M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 18% | XXX | XXX | XXX |
| EBIT | $143M | XXX | $119M | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $64.3M | XXX | $38.9M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $807M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, CompuGroup Medical's stock price is EUR 22 (or $25).
CompuGroup Medical has current market cap of EUR 1.1B (or $1.3B), and EV of EUR 1.8B (or $2.1B).
See CompuGroup Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.1B | $1.3B | XXX | XXX | XXX | XXX | $1.44 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, CompuGroup Medical has market cap of $1.3B and EV of $2.1B.
CompuGroup Medical's trades at 1.6x EV/Revenue multiple, and 8.9x EV/EBITDA.
Equity research analysts estimate CompuGroup Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CompuGroup Medical has a P/E ratio of 19.9x.
See valuation multiples for CompuGroup Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV (current) | $2.1B | XXX | $2.1B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 7.9x | XXX | 8.9x | XXX | XXX | XXX |
| EV/EBIT | 14.4x | XXX | 17.4x | XXX | XXX | XXX |
| EV/Gross Profit | 1.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 19.9x | XXX | 32.9x | XXX | XXX | XXX |
| EV/FCF | 39.2x | XXX | 28.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCompuGroup Medical's last 12 month revenue growth is 3%
CompuGroup Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
CompuGroup Medical's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CompuGroup Medical's rule of X is 28% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for CompuGroup Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | 21% | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 28% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 74% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CompuGroup Medical acquired XXX companies to date.
Last acquisition by CompuGroup Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . CompuGroup Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was CompuGroup Medical founded? | CompuGroup Medical was founded in 1987. |
| Where is CompuGroup Medical headquartered? | CompuGroup Medical is headquartered in Germany. |
| How many employees does CompuGroup Medical have? | As of today, CompuGroup Medical has 8.7K+ employees. |
| Is CompuGroup Medical publicy listed? | Yes, CompuGroup Medical is a public company listed on FRA. |
| What is the stock symbol of CompuGroup Medical? | CompuGroup Medical trades under COP ticker. |
| When did CompuGroup Medical go public? | CompuGroup Medical went public in 2008. |
| Who are competitors of CompuGroup Medical? | Similar companies to CompuGroup Medical include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of CompuGroup Medical? | CompuGroup Medical's current market cap is $1.3B |
| What is the current revenue of CompuGroup Medical? | CompuGroup Medical's last 12 months revenue is $1.3B. |
| What is the current revenue growth of CompuGroup Medical? | CompuGroup Medical revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of CompuGroup Medical? | Current revenue multiple of CompuGroup Medical is 1.6x. |
| Is CompuGroup Medical profitable? | Yes, CompuGroup Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of CompuGroup Medical? | CompuGroup Medical's last 12 months EBITDA is $262M. |
| What is CompuGroup Medical's EBITDA margin? | CompuGroup Medical's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of CompuGroup Medical? | Current EBITDA multiple of CompuGroup Medical is 7.9x. |
| What is the current FCF of CompuGroup Medical? | CompuGroup Medical's last 12 months FCF is $52.6M. |
| What is CompuGroup Medical's FCF margin? | CompuGroup Medical's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of CompuGroup Medical? | Current FCF multiple of CompuGroup Medical is 39.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
